A T-cell receptor associated with naturally occurring human tumor immunity. - Wikidata - wikimedia - TriplyDB

A T-cell receptor associated with naturally occurring human tumor immunity.

A T-cell receptor associated with naturally occurring human tumor immunity.

http://www.wikidata.org/entity/Q36277223

about

'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook MHC-restricted phosphopeptides from insulin receptor substrate-2 and CDC25b offer broad-based immunotherapeutic agents for cancer.Tolerance to the neuron-specific paraneoplastic HuD antigen.The onconeural antigen cdr2 is a novel APC/C target that acts in mitosis to regulate c-myc target genes in mammalian tumor cells.Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasis.Affinity maturation of T-cell receptor-like antibodies for Wilms tumor 1 peptide greatly enhances therapeutic potential.Human epidermal growth factor receptor 2 overexpression in breast cancer of patients with anti-Yo--associated paraneoplastic cerebellar degeneration A destructive feedback loop mediated by CXCL10 in central nervous system inflammatory disease.A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer.A novel approach to evaluate the immunogenicity of viral antigens of clinical importance in HLA transgenic murine models.Patients with lung cancer and paraneoplastic Hu syndrome harbor HuD-specific type 2 CD8+ T cells.Relationship between CD8-dependent antigen recognition, T cell functional avidity, and tumor cell recognition.Enhanced T cell receptor gene therapy for cancer.CTLA4 blockade elicits paraneoplastic neurological disease in a mouse model.Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response.T cells targeting a neuronal paraneoplastic antigen mediate tumor rejection and trigger CNS autoimmunity with humoral activation.Immunopathogenesis of paraneoplastic neurological syndromes associated with anti-Hu antibodies: A beneficial antitumor immune response going awry T cells presenting viral antigens or autoantigens induce cytotoxic T cell anergy.Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration.[The systemic evaluation and clinical significance of immunological function for advanced lung cancer patients].

P2860

Q26786089-F25D5498-D404-4031-928C-F4054D5120AF Q30303138-6941B38B-C0BE-4D32-BE32-335B2C4372DB Q33459207-7DF1AEC6-35A3-4CD0-8806-70126A687A80 Q33552315-72C3C0CB-D057-4171-86B9-14E258CF56EE Q34507534-7DE1E647-6A4E-4878-9E48-ECF47A5BDC05 Q35634680-60F3FD09-FC88-49EC-B17A-6DA82A50AE1B Q35845246-6F60F07D-3D72-4F27-B958-F0472A9955CC Q36094936-08625CF9-F452-43DC-93AD-445D2083B1A5 Q36958112-F39DB0B2-F70D-4C66-8B40-6C76E5DC386A Q36960608-1361FA47-3F85-4A36-AB92-481FE7F2CA9A Q37241339-8CEDE19F-6B0B-469A-9039-0AFC2EDCD3B2 Q37412169-09566A75-7D1D-46E2-9E32-6FA6E8AF0414 Q37702226-99C01283-D722-465B-9524-CB3529C4B597 Q39413457-3EE88F73-AFFF-4E43-8EC2-F86953940F20 Q39828324-3111DD72-7416-46ED-A5B7-5C779532FFFA Q41774005-BBC530E6-FC31-408C-A6F0-A062E91FCECE Q42610971-8AABD8C2-7624-4331-9E1B-E31A114A1128 Q45951645-FFF7E3EE-4E6B-4A8D-AC20-44D92855C0A6 Q47211573-31FEB4E4-66A8-4218-9B0F-EFE513EFBF50 Q55430751-DA4BA145-112C-4865-8A37-E25EEE135AC7

P2860

A T-cell receptor associated with naturally occurring human tumor immunity.

http://www.wikidata.org/entity/Q36277223

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

A T-cell receptor associated with naturally occurring human tumor immunity.

@ast

A T-cell receptor associated with naturally occurring human tumor immunity.

@en

type

label

A T-cell receptor associated with naturally occurring human tumor immunity.

@ast

A T-cell receptor associated with naturally occurring human tumor immunity.

@en

prefLabel

A T-cell receptor associated with naturally occurring human tumor immunity.

@ast

A T-cell receptor associated with naturally occurring human tumor immunity.

@en

P1433

Q36277223-2C8E7437-4552-4300-A600-D8B5AB7A28B2

P1476

Q36277223-AFA84E75-90E8-4259-89F4-B342E96E00EA

P2093

Q36277223-0529C176-5341-4C3A-A36E-28ADAC2485CB

Q36277223-5030D516-246E-4B99-AE4E-0EBD33DF9BCE

Q36277223-5430194F-2F4B-4F1A-8C9E-BFA822AA94C3

Q36277223-6773B6B0-20FF-410A-A419-9D696670D530

Q36277223-6DBA064D-4986-414A-BE41-4A5892E9B7F3

Q36277223-81EA8163-23C3-4783-B717-D81677EB3F69

Q36277223-87A4223A-E0EE-4E52-84B2-C218112BA832

Q36277223-CB4D85C7-0C9B-4315-9B91-8CA07ECEA688

Q36277223-FA53003D-9A6A-4592-91EA-11545EEDA49F

P2860

Q36277223-03B7BA7C-64D9-4C4A-9CD9-475CB086D642

Q36277223-111FAF0D-5CEC-4456-A2FF-C249511C1D91

Q36277223-14F96B64-EA03-4C7A-9817-04D736DE83C5

Q36277223-17C5C829-8353-4A74-A2C4-A05C87A97991

Q36277223-1B37C0AB-FB3C-472F-B680-CC01F5CCE3AA

Q36277223-1D6AAF97-3C79-4B70-8459-1A009935CC3D

Q36277223-1EBD285B-74FC-4CFB-9B84-4C93A65D9AC1

Q36277223-27C03D55-8A3E-41B4-A2B1-7A393351EF4F

Q36277223-327ABFD1-BF1F-4CED-AD93-1D92D4C98110

Q36277223-377C2B92-C4E5-4F43-AAE3-605CE4D7BF5A

P304

Q36277223-D9EF0CD2-9902-4A2C-95B4-7BE8EE725122

P31

Q36277223-A7CC0484-27D7-4663-970A-FAE0A4DD68B9

P356

Q36277223-8EF8288A-5CB5-444F-B2FD-7E4E4A43D53A

P407

Q36277223-52A15D3B-A2F5-428B-BABC-6B79BABDE00D

P433

Q36277223-C8B1C8AB-AEB9-4232-BA54-35AC6C7674E7

P478

Q36277223-2D5A6420-E0BF-41EF-9935-FAD5622C693A

P577

Q36277223-8BB964E0-757F-445D-96C3-95ED2315E116

P5875

Q36277223-C21464A3-6A0C-41DD-8EDB-66004FD808CC

P698

Q36277223-A60295A2-4B0A-4625-B714-EC5148CF3881

P932

Q36277223-A68FDE26-4211-4355-9C77-C273DF1C0CC9

P356

PNAS.0704336104

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

A T-cell receptor associated with naturally occurring human tumor immunity.

@en

P2093

Alan N Houghton

http://www.w3.org/2001/XMLSchema#string

Ashby Thomas

http://www.w3.org/2001/XMLSchema#string

Bianca D Santomasso

http://www.w3.org/2001/XMLSchema#string

Jerome B Posner

http://www.w3.org/2001/XMLSchema#string

Mark E Dudley

http://www.w3.org/2001/XMLSchema#string

Nathalie E Blachère

http://www.w3.org/2001/XMLSchema#string

Robert B Darnell

http://www.w3.org/2001/XMLSchema#string

Travis Williams

http://www.w3.org/2001/XMLSchema#string

Wendy K Roberts

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer immunotherapy: moving beyond current vaccines

Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain

T cell response to Hu-D peptides in patients with anti-Hu syndrome

A simplified system for generating recombinant adenoviruses

Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration

Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients

Peptides derived from the onconeural HuD protein can elicit cytotoxic responses in HHD mouse and human

Paraneoplastic neurological degenerations: keys to tumour immunity

Paraneoplastic syndromes affecting the nervous system

A post-transcriptional regulatory mechanism restricts expression of the paraneoplastic cerebellar degeneration antigen cdr2 to immune privileged tissues

P304

19073-19078

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0704336104

http://www.w3.org/2001/XMLSchema#string

P407

P433

48

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P577

2007-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5801718

http://www.w3.org/2001/XMLSchema#string

P698

18045792

http://www.w3.org/2001/XMLSchema#string

P932

2141910

http://www.w3.org/2001/XMLSchema#string